InvestorsHub Logo

H2R

Followers 41
Posts 2223
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Wednesday, 12/06/2023 8:57:33 AM

Wednesday, December 06, 2023 8:57:33 AM

Post# of 1088
Looking at M&A more closely?

https://ir.outlooktherapeutics.com/news-releases/news-release-details/outlook-therapeuticsr-announces-strategic-organizational

Effective immediately, Joel Prieve, formerly the Senior Vice President of Commercial Operations, has been appointed to the role of Senior Vice President of Licensing and M&A. In this role, he will be responsible for developing and executing the Company's strategy in the areas of licensing and partnerships, as well as evaluating and executing potential merger and acquisition opportunities.



Are there parties interested in acquiring OTLK??

Best of luck with your investments!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OTLK News